Early glucocorticoid withdrawal by combining rituximab with belimumab in two patients with lupus-associated thrombocytopenia

Rheumatology (Oxford). 2023 Nov 2;62(11):e315-e316. doi: 10.1093/rheumatology/kead171.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Glucocorticoids / therapeutic use
  • Humans
  • Immunosuppressive Agents
  • Lupus Erythematosus, Systemic* / complications
  • Lupus Erythematosus, Systemic* / drug therapy
  • Rituximab / therapeutic use
  • Thrombocytopenia* / drug therapy
  • Treatment Outcome

Substances

  • Rituximab
  • belimumab
  • Glucocorticoids
  • Antibodies, Monoclonal, Humanized
  • Immunosuppressive Agents